Selected research
Market Outlook & Growth Opportunities
Global Medical Device Calibration and Testing Market Outlook and Growth Opportunities 2026
Market perspective
The global Medical Device Calibration and Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Medical Device Calibration and Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Medical Device Calibration and Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Medical Device Calibration and Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Medical Device Calibration and Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Medical Device Calibration and Testing market include NS Medical Systems, Transcat, JM Test Systems, JPen Medical, TAG Medical, Hospicare Equipment Services Corp, Tektronix, Fluke Biomedical and Biomedical Technologies, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Medical Device Calibration and Testing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Medical Device Calibration and Testing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Medical Device Calibration and Testing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Medical Device Calibration and Testing market.
Medical Device Calibration and Testing Segment by Company
NS Medical Systems
Transcat
JM Test Systems
JPen Medical
TAG Medical
Hospicare Equipment Services Corp
Tektronix
Fluke Biomedical
Biomedical Technologies
Medical Device Calibration and Testing Segment by Type
Calibration Service
Testing Service
Medical Device Calibration and Testing Segment by Application
Hospital
Medical Device Manufacturer
Others
Medical Device Calibration and Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Medical Device Calibration and Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Medical Device Calibration and Testing key companies, revenue, market share, and recent developments.
3. To split the Medical Device Calibration and Testing breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Medical Device Calibration and Testing market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Medical Device Calibration and Testing significant trends, drivers, influence factors in global and regions.
6. To analyze Medical Device Calibration and Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Device Calibration and Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Device Calibration and Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Device Calibration and Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medical Device Calibration and Testing industry.
Chapter 3: Detailed analysis of Medical Device Calibration and Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Medical Device Calibration and Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Medical Device Calibration and Testing in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Calibration Service
- Testing Service
Applications
- Hospital
- Medical Device Manufacturer
- Others
Companies covered
- NS Medical Systems
- Transcat
- JM Test Systems
- JPen Medical
- TAG Medical
- Hospicare Equipment Services Corp
- Tektronix
- Fluke Biomedical
- Biomedical Technologies
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Medical Device Calibration and Testing Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Medical Device Calibration and Testing Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Medical Device Calibration and Testing Market Dynamics
- 2.1 Medical Device Calibration and Testing Industry Trends
- 2.2 Medical Device Calibration and Testing Industry Drivers
- 2.3 Medical Device Calibration and Testing Industry Opportunities and Challenges
- 2.4 Medical Device Calibration and Testing Industry Restraints
3 Medical Device Calibration and Testing Market by Company
- 3.1 Global Medical Device Calibration and Testing Company Revenue Ranking in 2025
- 3.2 Global Medical Device Calibration and Testing Revenue by Company (2021-2026)
- 3.3 Global Medical Device Calibration and Testing Company Ranking (2024-2026)
- 3.4 Global Medical Device Calibration and Testing Company Manufacturing Base and Headquarters
- 3.5 Global Medical Device Calibration and Testing Company Product Type and Application
- 3.6 Global Medical Device Calibration and Testing Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Medical Device Calibration and Testing Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Medical Device Calibration and Testing Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Medical Device Calibration and Testing Market by Type
- 4.1 Medical Device Calibration and Testing Type Introduction
- 4.1.1 Calibration Service
- 4.1.2 Testing Service
- 4.2 Global Medical Device Calibration and Testing Sales Value by Type
- 4.2.1 Global Medical Device Calibration and Testing Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Medical Device Calibration and Testing Sales Value by Type (2021-2032)
- 4.2.3 Global Medical Device Calibration and Testing Sales Value Share by Type (2021-2032)
5 Medical Device Calibration and Testing Market by Application
- 5.1 Medical Device Calibration and Testing Application Introduction
- 5.1.1 Hospital
- 5.1.2 Medical Device Manufacturer
- 5.1.3 Others
- 5.2 Global Medical Device Calibration and Testing Sales Value by Application
- 5.2.1 Global Medical Device Calibration and Testing Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Medical Device Calibration and Testing Sales Value by Application (2021-2032)
- 5.2.3 Global Medical Device Calibration and Testing Sales Value Share by Application (2021-2032)
6 Medical Device Calibration and Testing Regional Value Analysis
- 6.1 Global Medical Device Calibration and Testing Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Medical Device Calibration and Testing Sales Value by Region (2021-2032)
- 6.2.1 Global Medical Device Calibration and Testing Sales Value by Region: 2021-2026
- 6.2.2 Global Medical Device Calibration and Testing Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Medical Device Calibration and Testing Sales Value (2021-2032)
- 6.3.2 North America Medical Device Calibration and Testing Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Medical Device Calibration and Testing Sales Value (2021-2032)
- 6.4.2 Europe Medical Device Calibration and Testing Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Medical Device Calibration and Testing Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Medical Device Calibration and Testing Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Medical Device Calibration and Testing Sales Value (2021-2032)
- 6.6.2 South America Medical Device Calibration and Testing Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Medical Device Calibration and Testing Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Medical Device Calibration and Testing Sales Value Share by Country, 2025 VS 2032
7 Medical Device Calibration and Testing Country-level Value Analysis
- 7.1 Global Medical Device Calibration and Testing Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Medical Device Calibration and Testing Sales Value by Country (2021-2032)
- 7.2.1 Global Medical Device Calibration and Testing Sales Value by Country (2021-2026)
- 7.2.2 Global Medical Device Calibration and Testing Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Medical Device Calibration and Testing Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Medical Device Calibration and Testing Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Medical Device Calibration and Testing Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Medical Device Calibration and Testing Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Medical Device Calibration and Testing Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Medical Device Calibration and Testing Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Medical Device Calibration and Testing Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Medical Device Calibration and Testing Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Medical Device Calibration and Testing Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Medical Device Calibration and Testing Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Medical Device Calibration and Testing Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Medical Device Calibration and Testing Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Medical Device Calibration and Testing Sales Value Growth Rate (2021-2032)
- 7.7.2 France Medical Device Calibration and Testing Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Medical Device Calibration and Testing Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Medical Device Calibration and Testing Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Medical Device Calibration and Testing Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Medical Device Calibration and Testing Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Medical Device Calibration and Testing Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Medical Device Calibration and Testing Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Medical Device Calibration and Testing Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Medical Device Calibration and Testing Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Medical Device Calibration and Testing Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Medical Device Calibration and Testing Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Medical Device Calibration and Testing Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Medical Device Calibration and Testing Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Medical Device Calibration and Testing Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Medical Device Calibration and Testing Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Medical Device Calibration and Testing Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Medical Device Calibration and Testing Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Medical Device Calibration and Testing Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Medical Device Calibration and Testing Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Medical Device Calibration and Testing Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Medical Device Calibration and Testing Sales Value Growth Rate (2021-2032)
- 7.14.2 China Medical Device Calibration and Testing Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Medical Device Calibration and Testing Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Medical Device Calibration and Testing Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Medical Device Calibration and Testing Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Medical Device Calibration and Testing Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Medical Device Calibration and Testing Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Medical Device Calibration and Testing Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Medical Device Calibration and Testing Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Medical Device Calibration and Testing Sales Value Growth Rate (2021-2032)
- 7.17.2 India Medical Device Calibration and Testing Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Medical Device Calibration and Testing Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Medical Device Calibration and Testing Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Medical Device Calibration and Testing Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Medical Device Calibration and Testing Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Medical Device Calibration and Testing Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Medical Device Calibration and Testing Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Medical Device Calibration and Testing Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Medical Device Calibration and Testing Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Medical Device Calibration and Testing Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Medical Device Calibration and Testing Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Medical Device Calibration and Testing Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Medical Device Calibration and Testing Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Medical Device Calibration and Testing Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Medical Device Calibration and Testing Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Medical Device Calibration and Testing Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Medical Device Calibration and Testing Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Medical Device Calibration and Testing Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Medical Device Calibration and Testing Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Medical Device Calibration and Testing Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Medical Device Calibration and Testing Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Medical Device Calibration and Testing Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Medical Device Calibration and Testing Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Medical Device Calibration and Testing Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Medical Device Calibration and Testing Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Medical Device Calibration and Testing Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Medical Device Calibration and Testing Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Medical Device Calibration and Testing Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Medical Device Calibration and Testing Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Medical Device Calibration and Testing Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Medical Device Calibration and Testing Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Medical Device Calibration and Testing Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Medical Device Calibration and Testing Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Medical Device Calibration and Testing Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Medical Device Calibration and Testing Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Medical Device Calibration and Testing Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Medical Device Calibration and Testing Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Medical Device Calibration and Testing Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Medical Device Calibration and Testing Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Medical Device Calibration and Testing Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Medical Device Calibration and Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 NS Medical Systems
- 8.1.1 NS Medical Systems Company Information
- 8.1.2 NS Medical Systems Business Overview
- 8.1.3 NS Medical Systems Medical Device Calibration and Testing Revenue and Gross Margin (2021-2026)
- 8.1.4 NS Medical Systems Medical Device Calibration and Testing Product Portfolio
- 8.1.5 NS Medical Systems Recent Developments
- 8.2 Transcat
- 8.2.1 Transcat Company Information
- 8.2.2 Transcat Business Overview
- 8.2.3 Transcat Medical Device Calibration and Testing Revenue and Gross Margin (2021-2026)
- 8.2.4 Transcat Medical Device Calibration and Testing Product Portfolio
- 8.2.5 Transcat Recent Developments
- 8.3 JM Test Systems
- 8.3.1 JM Test Systems Company Information
- 8.3.2 JM Test Systems Business Overview
- 8.3.3 JM Test Systems Medical Device Calibration and Testing Revenue and Gross Margin (2021-2026)
- 8.3.4 JM Test Systems Medical Device Calibration and Testing Product Portfolio
- 8.3.5 JM Test Systems Recent Developments
- 8.4 JPen Medical
- 8.4.1 JPen Medical Company Information
- 8.4.2 JPen Medical Business Overview
- 8.4.3 JPen Medical Medical Device Calibration and Testing Revenue and Gross Margin (2021-2026)
- 8.4.4 JPen Medical Medical Device Calibration and Testing Product Portfolio
- 8.4.5 JPen Medical Recent Developments
- 8.5 TAG Medical
- 8.5.1 TAG Medical Company Information
- 8.5.2 TAG Medical Business Overview
- 8.5.3 TAG Medical Medical Device Calibration and Testing Revenue and Gross Margin (2021-2026)
- 8.5.4 TAG Medical Medical Device Calibration and Testing Product Portfolio
- 8.5.5 TAG Medical Recent Developments
- 8.6 Hospicare Equipment Services Corp
- 8.6.1 Hospicare Equipment Services Corp Company Information
- 8.6.2 Hospicare Equipment Services Corp Business Overview
- 8.6.3 Hospicare Equipment Services Corp Medical Device Calibration and Testing Revenue and Gross Margin (2021-2026)
- 8.6.4 Hospicare Equipment Services Corp Medical Device Calibration and Testing Product Portfolio
- 8.6.5 Hospicare Equipment Services Corp Recent Developments
- 8.7 Tektronix
- 8.7.1 Tektronix Company Information
- 8.7.2 Tektronix Business Overview
- 8.7.3 Tektronix Medical Device Calibration and Testing Revenue and Gross Margin (2021-2026)
- 8.7.4 Tektronix Medical Device Calibration and Testing Product Portfolio
- 8.7.5 Tektronix Recent Developments
- 8.8 Fluke Biomedical
- 8.8.1 Fluke Biomedical Company Information
- 8.8.2 Fluke Biomedical Business Overview
- 8.8.3 Fluke Biomedical Medical Device Calibration and Testing Revenue and Gross Margin (2021-2026)
- 8.8.4 Fluke Biomedical Medical Device Calibration and Testing Product Portfolio
- 8.8.5 Fluke Biomedical Recent Developments
- 8.9 Biomedical Technologies
- 8.9.1 Biomedical Technologies Company Information
- 8.9.2 Biomedical Technologies Business Overview
- 8.9.3 Biomedical Technologies Medical Device Calibration and Testing Revenue and Gross Margin (2021-2026)
- 8.9.4 Biomedical Technologies Medical Device Calibration and Testing Product Portfolio
- 8.9.5 Biomedical Technologies Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst